Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Napredno
  • Assessment of pain improvement...
  • Citiraj
  • Pošljite SMS
  • Pošljite email
  • Natisni
  • Izvozi zadetek
    • Izvozi v RefWorks
    • Izvozi v EndNoteWeb
    • Izvozi v EndNote
  • Permanent link
Assessment of pain improvement in rheumatoid arthritis patients treated with baricitinib, who were inadequate responders to methotrexate and tumor necrosis factor inhibitors

Assessment of pain improvement in rheumatoid arthritis patients treated with baricitinib, who were inadequate responders to methotrexate and tumor necrosis factor inhibitors

Bibliografske podrobnosti
Main Authors: Taylor, P, Fleischmann, R, Takeuchi, T, Pope, J, Genovese, M, Zhu, B, Gaich, C, Zhang, X, Dickson, C, Quebe, A, De Leonardis, F, Cardoso, A, Kouris, I, Durez, P
Format: Conference item
Jezik:English
Izdano: Oxford University Press 2019
  • Zaloga
  • Opis
  • Podobne knjige/članki
  • Knjižničarski pogled

Podobne knjige/članki

  • Achieving pain control in rheumatoid arthritis with baricitinib or ddalimumab plus methotrexate: Results from the RA-BEAM Trial
    od: Taylor, P, et al.
    Izdano: (2019)
  • Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy
    od: Taylor, P, et al.
    Izdano: (2022)
  • Improved patient-reported outcomes in patients with rheumatoid arthritis who failed adalimumab or placebo treatment and were rescued with baricitinib
    od: Fautrel, B, et al.
    Izdano: (2017)
  • Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate.
    od: Keystone, E, et al.
    Izdano: (2015)
  • Effect of baricitinib and adalimumab in reducing pain and improving function in patients with rheumatoid arthritis in low disease activity: exploratory analyses from RA-BEAM
    od: Fautrel, B, et al.
    Izdano: (2019)

Iskalne možnosti

  • Iskalna zgodovina
  • Napredno iskanje

Poišči več

  • Prelistaj katalog
  • Po abecedi
  • Explore Channels
  • Obvezna literatura
  • Novi knjige/članki

Potrebujete pomoč?

  • Navodila za iskanje
  • Vprašaj knjižničarja
  • Pogosta vprašanja